Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae [1]
- Calvo, A.
- Giménez, M.J.
- Alou, L.
- Gómez-Lus, M.L.
- Aguilar, L.
- Prieto, J.
ISSN: 0924-8579
Année de publication: 2002
Volumen: 20
Número: 2
Pages: 144-146
Type: Lettre
